Lukáš, M., Hrubá, V., Reissigová, J., Černá, K., Machková, N., Ďuricová, D., Kolář, M., Vlková, K., Čermáková, L., Lukáš Jr., M. Switch from biosimilar infliximab CT-P13 to biosimilar infliximab SB-2 in the long-term maintenance therapy in IBD patients – prospective observational study. Gastroenterologie a hepatologie. 2023, 77(4), 336-341. ISSN 1804-7874. Available: https://doi.org/10.48095/ccgh2023336.